Glomerular Disease Events

Rare Disease Day is a globally coordinated movement dedicated to rare diseases, striving for equity in social opportunities, healthcare, and access to diagnosis and therapies for people living with a rare disease.

Since its creation in 2008, Rare Disease Day has played a crucial role in building an international rare disease community—multi-disease, global, and diverse, yet united in purpose.

Rare Disease Day is observed every year on 28 February (or 29 February in leap years—the rarest day of the year). It was established and is coordinated by EURORDIS in partnership with over 70 national alliance patient organisations. The day serves as a powerful focal point, driving advocacy efforts at local, national, and international levels.

Learn More:
https://www.rarediseaseday.org/

More info: https://www.pnrconsortium.org/events/2E06A432-BA41-497A-BD1A-56693D8C8793

Registration will open October 13, 2025

• 16-hour Course over 2 days
• Cost: 45 - 400 euros
• The closing date for booking a place is 26th February 2026.

Overview
Genomic testing is transforming nephrology — from diagnosing inherited kidney disease to guiding treatment, counselling families, and shaping service design.
This short course provides a practical, clinically‑focused update on the principles and practice of genomic medicine in kidney disease.
You’ll learn how to choose the right genetic test for a patient’s phenotype, interpret reports (including VUS), counsel patients and families, and apply genomics across common genetic kidney diseases including ADPKD, ADTKD and Alport syndrome.
Who this course is for
This course is suitable for:

• adult and paediatric nephrology consultants and trainees
• clinical genetics consultants and trainees
• transplant physicians and surgeons
• renal clinical nurse specialists and transplant/living donor coordinators
• genetic counsellors and allied health professionals working with kidney patients
• clinical scientists and laboratory staff involved in renal genomics

Course content
Day 1 - Fundamentals, cystic kidney disease & counselling
Thursday 5th March 2026 (09:00-17:00)
Session 1: Introduction to genomics

• A patient perspective on living with ADPKD 
• A patient perspective on living with Alport syndrome 
• Genetics in kidney disease  — DNA, types of variation, inheritance, mechanisms
• Genomic testing & variant interpretation 
• A clinical geneticist’s approach to inherited kidney disorders 

Session 2: Cystic kidney disease

• Management of ADPKD in 2025 
• Tolvaptan and upcoming clinical trials 
• HNF1B‑related kidney disease 
• ARPKD 
• Ciliopathies / nephronophthisis 
• CAKUT 

Session 3: Genetic counselling

• Counselling considerations in inherited kidney disorders 
• Small‑group case discussions
• Plenary lecture: The Generation Study
• Drinks reception

Day 2 - Tubulo‑interstitial, Alport, glomerular & other inherited disorders
Friday 6th March 2026 (09:00-17:00)
Session 1: Tubulo‑interstitial disease

• Inherited tubulopathies 
• Metabolic kidney disorders 
• ADTKD 

Session 2: Alport syndrome

• X‑linked and AR Alport syndrome 
• Heterozygous COL4A3/4 variants 

Session 3: Inherited glomerulopathies

• Genetics of nephrotic syndrome 
• APOL1‑mediated kidney disease 
• Complement‑mediated kidney disease 
• Small‑group case discussions — genetics in transplantation

Session 4: Other inherited kidney disorders

• Unexplained kidney failure 
• Tuberous sclerosis 
• Kidney cancer syndromes 

Teaching and structure

• Interactive lectures with Q&A
• All livestreamed with the ability to interact in the chat during Q&A and case based discussion.
• Patient perspectives
   
• Small‑group case discussions focused on test selection, VUS interpretation and transplant donor genomics
• Plenary lecture on large‑scale genomic research
• Networking drinks reception after Day 1

You can attend either one or both days of the course. An online-only attendance option is also available.
Certificate and accreditation
Participants will receive a Certificate of Attendance. Similar courses previously offered by the department have been accredited with 12 Category 1 (external) CPD credits by the Royal College of Physicians (UK), and we anticipate the same accreditation for this course.
Learning outcomes
At the end of the course you should be able to:

1. Recall core principles of genomics, including types of DNA variation, mechanisms of disease and inheritance patterns.
2. Understand genomic testing technologies and select the most appropriate modality for a patient’s phenotype.
3. Identify and assess individuals at risk of genetic kidney disease.
4. Conduct genetic counselling covering implications for family members, uncertainty over results and predictive testing.
5. Interpret genetic test reports, including the implications of variants of uncertain significance (VUS).
6. Describe the investigation and management of genetic kidney diseases, including ADPKD, ADTKD and Alport syndrome.
7. Recognise the impact genetic kidney disease can have on affected families.
8. Consider the present and future clinical and ethical impact of novel genomic approaches in nephrology.
9. Explore the development of local and national genomic medicine services in the NHS.

Although some of the statistics and guidelines discussed on the course are UK specific, the key concepts and learning aims are relevant internationally.
Costs and concessions
Early bird fees (until 30th November) per day

• Consultants: £220 (In Person), £180 (Online)
• Resident doctors / Physician Associates: £205 (In Person), £135 (Online)
• NHS Allied Health (CNS, etc.): £100 (In Person), £40 (Online)
• RFH / UCL / UCLH SpRs / PAs: £145 (In Person), £90 (Online)

Early bird fees (until 30th November) for two days

• Consultants: £350 (In Person), £270 (Online)
• Resident doctors / Physician Associates: £300 (In Person), £250 (Online)
• NHS Allied Health (CNS, etc.): £170 (In Person), £70 (Online)
• RFH / UCL / UCLH SpRs / PAs: £250 (In Person), £180 (Online)

Fees per day after 30th November

• Consultants: £245 (In Person), £200 (Online)
• Resident doctors / Physician Associates: £230 (In Person), £150 (Online)
• NHS Allied Health (CNS, etc.): £110 (In Person), £45 (Online)
• RFH / UCL / UCLH SpRs / PAs: £160 (In Person), £100 (Online)

Fees for two days after 30th November

• Consultants: £400 (In Person), £300 (Online)
• Resident doctors / Physician Associates: £350 (In Person), £280 (Online)
• NHS Allied Health (CNS, etc.): £200 (In Person), £80 (Online)
• RFH / UCL / UCLH SpRs / PAs: £300 (In Person), £200 (Online)

 
Course Team: 

• Professor Daniel Gale
• Dr Charlotte Barker
• Dr Zainab Arslan
• Dr Melanie Chan
• Dr Omid Sadeghi-Alavijeh

Learn more here: https://www.kpmp.org/meetings-events

More information and registration: https://espnresearchconference.org/

ESPN is excited to invite you to join the 2nd ESPN Research Conference from March 12-14, 2026 which will bring together scientists and clinicians to share innovative research and inspiring new ideas about Paediatric Nephrology.

The ESPN Research Conference is complementary to the annual ESPN congress (Paediatric Kidney Week). It aims to discuss emerging topics in pediatric nephrology and to exchange ideas with basic scientists in order to gain insights into disease mechanisms and effects of novel treatments.

In 2026 we will focus on the latest pre-publication research on the role of complement in kidney diseases, particularly on the challenges of diagnosing and identifying these patients and on the potential of new complement inhibitors to transform and improve the treatment of children affected by different forms of complement-mediated nephropathies.

We will offer a program that ensures extensive discussions in scientific sessions and networking activities to advance research ideas, promote collaboration, and establish the culture of innovation.

We will reserve a large space in the program for free oral presentations and posters, allowing young and more experienced researchers to present and discuss their latest work with experts in the field.

Join your peers to discuss the latest research in a stimulating retreat atmosphere!
We look forward to meeting you in Florence!

Overview
This course is designed to provide the practicing Nephrologist with a complete understanding of the optimal management of chronic kidney diseases. The focus of this course will be to discuss the pathophysiologic and clinical advances in the major areas of Nephrology including glomerular disease, acid base and fluid and electrolyte disorders, hypertension, dialysis, and renal transplantation. Well recognized medical complications and recommendations for optimal care will be discussed to help reduce gaps in care.

WHY ATTEND?
Past attendees report an immediate impact on their practice and patient outcomes resulting from what they learned at this course. You will leave the program with:

• The latest nephrology knowledge, insight and teachings from leading authorities and clinical educators
• A greater understanding of how to apply the latest tools and tests in your practice
• Evidence-based treatment plans
• Individualized therapy and management strategies
• Specific management strategies and recommendations to optimize care in complex cases

Practitioners from around the world attend this comprehensive course to ensure they are current with the latest updates and advances in the diagnosis and treatment of kidney diseases. We hope you will join us in March!
Who Should Attend

• Nephrologists
• Internists
• Family-medicine physicians
• Physician associates
• Nurse practitioners
• Healthcare providers interested in refreshing their knowledge
• Physicians preparing for the nephrology boards
• Scientists engaged in nephrology research

 
Register Early & Save
This program is among the highest-rated Harvard Medical School CME courses.
Register by February 2, 2026, for discounted pricing!


Credits & Accreditation

• 48.00 AMA PRA Category 1 Credits™
• 48.00 ABIM MOC Points
• 48.00 ECMECs® Credits
• 9.75 Risk Management Credits
• Commensurate Credits from the Royal College of Physicians and Surgeons of Canada and the European Union of Medical Specialists

More information and registration: https://ckd3-summit.com/about-event/

Please save the date and find more information below:

https://vasculitis-melbourne2026.com/

WCN will be held in Yokohama, Japan March 28th to 31st, 2026.

75+ inspiring sessions in global health and 6 pre-congress courses. Then join the Global Kidney Village and Exhibition Hall for Spotlight sessions, Table Talks, quizzes and much more.

Present your research, increase your visibility, and exchange findings with other kidney care professionals at the WCN poster sessions, which feature hundreds of research projects.

Expand your kidney care network to know no boundaries: with 4000+ delegates and 200+ speakers from 130+ countries.

To learn more visit here!

Chronic kidney disease (CKD) research has reached a pivotal moment, with new discoveries revealing convergent disease mechanisms that drive organ failure and connect kidney disease to cardiovascular morbidity and mortality. The Keystone Symposia conference will accelerate progress by uniting global insights into kidney biology, precision medicine, and therapeutic innovation. The program will explore insights into kidney cellular architecture and deep tissue-level mapping that drive novel drug discovery approaches and model system design. In addition, For the first time, CKD trials will also be used as discovery engines to define mechanisms of action in humans. In addition, the interplay between genetic, environmental, and social determinants of kidney failure will be addressed. 
As a joint meeting with our longstanding conference on liver disease: Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk, we will connect these two communities focused on different organ systems to foster cross-disciplinary insights and collaborations towards illuminating overlapping biology, disease mechanisms and therapeutic avenues in these areas, particular with regard to incretin-based therapeutics. 
In the video below, Dr. Matthias Kretzler from the University of Michigan and Dr. Maria Chiara Magnone from Abiologics Inc., talk about what to expect from this meeting and why you should attend: https://youtu.be/Dl9ZxAnZoK4

Learn more here: https://www.keystonesymposia.org/conferences/conference-listing/meeting/M22026

More info: https://www.renalmd.org/page/AnnualMeeting

Save the date! April 23/24, 2026
Artificial Intelligence in Nephrology Conference at University of California, San Diego, 
This event will bring together leading clinicians, researchers, and data scientists to explore the transformative role of artificial intelligence in nephrology—from predictive analytics and imaging to clinical decision support and personalized care. 

Keynote speakers: 

• Dr. Navdeep Tangri - Role of AI in Kidney care
• Dr. Laura Barisoni: AI and computational Nephropathology

Travel grants (sponsored by American Society of Nephrology) available for trainees and early career faculty. See website below for more information.
https://ucsd.cloud-cme.com/course/courseoverview?P=0&EID=15610&IsExhibitor=false

Additional information: https://www.kidney.org/spring-clinical

Don’t miss this star-studded programme of speakers in an amazing venue, coming together to learn more about the rapidly evolving world of glomerular diseases.

Register Here: https://forms.office.com/pages/responsepage.aspx?id=slTDN7CF9UeyIge0jXdO48ndXQB4XbZEihbmIOEINfNUQ1dFTFNUTVUxUkoxVEVUSVk5UlozUEQ3NC4u&origin=QRCode&qrcodeorigin=presentation&route=shorturl 

For more information: https://www.era-online.org/events/glasgow-2026/

PROGRAM DESCRIPTION AND OBJECTIVES
The course is designed to assist nephrologists and renal pathologists (including nephrology and renal pathology trainees) in diagnosing and managing the most common forms of medical renal disease, including diseases that target the glomerulus, tubules, interstitium, and blood vessels.

The activity will span three days and include lectures covering the following content areas: Nephrotic syndrome, Nephritic syndrome, Genetics, Tubulointerstitial, Vascular Disease, Transplant & Dysproteinemia. These lectures will be delivered live in front of an audience but also streamed simultaneously for virtual participants; all participants will have access to these lectures for 3 months after the conference.

Upon completion of this activity, participants will be better able to: 

• Identify the role of complement in the pathophysiology of glomerular diseases and how novel complement-targeting therapies can fit into treatment patterns.
• Enhance diagnostic suspicion for a genetically mediated form of glomerular disease and facilitate rapid referral for genetic testing.
• Assess which patients would benefit from repeat biopsies in the management of their glomerular diseases.

Link: https://events.columbia.edu/cal/event/eventView.do?b=de&calPath=/public/cals/MainCal&guid=CAL-00bbdb71-99e1c426-0199-e3dc422c-000044f7events%40columbia.edu&recurrenceId= 

NBLU is a unique week-long program tailored to second-year nephrology fellows preparing to begin a career in nephrology. Rotations are designed to provide nephrology fellows with an opportunity to complement the clinical skills gained through their fellowship program with learning modules focused on the economics and business aspects of private practice. Attendees will leave the NBLU program with a stronger understanding of the business of nephrology and how it fits into the complex and evolving healthcare landscape. 

To learn more: https://nbluniv.org/ 

Learn More Here: https://www.kpmp.org/meetings-events

For more information: https://www.espn-online.org/latest-espn-meeting/

More information: https://www.dgfn.eu/veranstaltungen-nach-jahr.html?year=2026

The 2026 ISGD Clinical Trials Innovation Summit will serve as a global hub for clinical trialists, nephrologists, and other stakeholders committed to transforming the future of kidney disease research. Convening world-renowned keynote speakers and innovative collaborative formats, the Summit is designed to accelerate innovation, catalyze collaboration, and design solutions to the key challenges of clinical trials in glomerular diseases and beyond.

This inaugural Clinical Trials Innovation Summit will spotlight the most pressing challenges in clinical trial design, patient stratification, new drug target identification, and regulatory endpoints. Hosted by the International Society of Glomerular Disease (ISGD) in partnership with the renowned nephrology and clinical trials leadership team of the University of Texas Medical Branch, the Clinical Trials Innovation Summit will fuse scientific rigor, operational excellence, and hands-on engagement.

For more information and registration, visit https://www.is-gd.org/2026-cts

21st Congress of the International Pediatric Nephrology Association
More information: https://ipna2027.org/

For more information: https://www.theisn.org/in-action/events/world-congress-of-nephrology

Additional information: https://www.kidney.org/spring-clinical

More information: https://www.era-online.org/events/rotterdam-2027/

Join us in Ann Arbor, Michigan for the 16th International Podocyte Conference.

For more information: https://www.espn-online.org/latest-espn-meeting/

Additional information: https://www.kidney.org/spring-clinical

For more information: https://www.theisn.org/in-action/events/world-congress-of-nephrology